Unknown

Dataset Information

0

Pathological hypertrophy reverses β2-adrenergic receptor-induced angiogenesis in mouse heart.


ABSTRACT: β-adrenergic activation and angiogenesis are pivotal for myocardial function but the link between both events remains unclear. The aim of this study was to explore the cardiac angiogenesis profile in a mouse model with cardiomyocyte-restricted overexpression of β2-adrenoceptors (β2-TG), and the effect of cardiac pressure overload. β2-TG mice had heightened cardiac angiogenesis, which was essential for maintenance of the hypercontractile phenotype seen in this model. Relative to controls, cardiomyocytes of β2-TGs showed upregulated expression of vascular endothelial growth factor (VEGF), heightened phosphorylation of cAMP-responsive-element-binding protein (CREB), and increased recruitment of phospho-CREB, CREB-binding protein (CBP), and p300 to the VEGF promoter. However, when hearts were subjected to pressure overload by transverse aortic constriction (TAC), angiogenic signaling in β2-TGs was inhibited within 1 week after TAC. β2-TG hearts, but not controls, exposed to pressure overload for 1-2 weeks showed significant increases from baseline in phosphorylation of Ca(2+)/calmodulin-dependent kinase II (CaMKIIδ) and protein expression of p53, reduction in CREB phosphorylation, and reduced abundance of phospho-CREB, p300 and CBP recruited to the CREB-responsive element (CRE) site of VEGF promoter. These changes were associated with reduction in both VEGF expression and capillary density. While non-TG mice with TAC developed compensatory hypertrophy, (2-TGs exhibited exaggerated hypertrophic growth at week-1 post-TAC, followed by LV dilatation and reduced fractional shortening measured by serial echocardiography. In conclusion, angiogenesis was enhanced by the cardiomyocyte (2AR/CREB/VEGF signaling pathway. Pressure overload rapidly inhibited this signaling, likely as a consequence of activated CaMKII and p53, leading to impaired angiogenesis and functional decompensation.

SUBMITTER: Xu Q 

PROVIDER: S-EPMC4393171 | BioStudies | 2015-01-01

SECONDARY ACCESSION(S): U41383

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC4101649 | BioStudies
2017-01-01 | S-EPMC5619801 | BioStudies
2020-01-01 | S-EPMC7011135 | BioStudies
2018-01-01 | S-EPMC5891926 | BioStudies
2014-01-01 | S-EPMC4041651 | BioStudies
2013-01-01 | S-EPMC3695923 | BioStudies
2014-01-01 | S-EPMC4177887 | BioStudies
1000-01-01 | S-EPMC5357304 | BioStudies
2013-01-01 | S-EPMC3601083 | BioStudies
2019-01-01 | S-EPMC6777911 | BioStudies